Dr. Ganesh Prasad Jaiswal*, Dr. Mihir Kumar Biswas, Dr. Beulah Milton, Dr. L. Padma and
Dr. Narayanaswamay V.B.


Introduction: Hypertension, also known as high or elevated blood pressure, is a condition in which the blood vessels have persistently raised pressure. Objective: TO conduct a retrospective and prospective study on drug utilization evaluation of antihypertensive drugs.Methodology: Drug use utilization data of 150 patients, attending inpatients and out patient’s department of Sapthagiri Hospital was collected from patient’s case Notes and prescriptions. This study is retrospective and prospective observational study. The data were analysed to find out the demographic characteristics of the patients, number of drugs prescribed per patients, drugs which are commonly prescribed, mono therapy, combination therapy (two drug therapy, three drug therapy), route of administration, adherence with JNC VIII, drug treatment based on stages of hypertension, co-morbidities of patients. Patients suffering from hypertension with or without co-morbid conditions were included in the study. Result: During the 6-month period of study 150 prescription for Hypertension were analysed. Among 150 prescriptions most of the patients were female (56.66%) while (43.33%) were male and major age group having HTN was found to be 51-60 years (30.66%). Regarding co-morbidity 33.33% patients had HTN with DM. the study revealed that most of the patients were on combination therapy of anti-hypertensive drugs (63.33%) while 36.66% patients received mono therapy. Mostly prescribed rout of administration was oral route (86.66%). Among 150 prescriptions 85.34% of prescription were found to be adhered with JNC VIII guidelines. Conclusion: 14.67% deviation from JNC VIII guidelines and 16.67% prescription had drug interaction was observed in the treatment with respect to selection of antihypertensive drugs.

Keywords: drug utilization, co-morbidities, antihypertensive, JNC VII, DI.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MARCH 2024 Issue has been successfully launched on 1 MARCH 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction